Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for reducing recurrence in steroid-dependent nephrotic syndrome in children
IRCT20111024007892N9Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of montelukast and prednisolone in nephrosis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Urine protein to creatinine ratio, Serum albumin and 4 more. Started Oct 2019; status: completed.
02
Drugs
montelukastprednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT20111024007892N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111024007892N9.